Viridian TherapeuticsVRDN
13F holders, Q4 2024 (December 31)178holders +13
30new positions
24sold out
7famous investors
$19.17avg. 13F price*
At the end of Q4 2024, 178 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, up 13 from Q3 2024. 30 opened new positions and 24 sold out. The largest holders were FMR LLC ($227.8M), BlackRock, Inc. ($110.4M) and Vanguard Group Inc. ($88.1M). 7 famous investors held it, including Lee Ainslie (0.7% of Maverick Capital's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 30 | $57.5M |
| Exits | 24 | $89.0M |
All 13F filers, Q3 2024 → Q4 2024: 14,109,197 shares bought and 10,167,230 shares sold, net +3,941,967 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 178 holders
| FMR LLC | 0.01% | Add +6.3% | 11,881,912 | $227.8M |
| BlackRock, Inc. | 0.00% | Add +19.9% | 5,758,577 | $110.4M |
| Vanguard Group Inc. | 0.00% | Add +4.0% | 4,595,049 | $88.1M |
| Deep Track Capital, LP | 3.25% | Add +20.6% | 4,522,741 | $86.7M |
| Venrock Adviser, LLC | 5.11% | No change | 3,882,709 | $74.4M |
| State Street Corp. | 0.00% | Add +48.0% | 3,522,566 | $67.5M |
| Fairmount Funds Management LLC | 6.57% | No change | 3,445,813 | $66.1M |
| Kynam Capital Management, LP | 4.21% | Add +32.5% | 3,326,262 | $63.8M |
| Tang Capital Management LLC | 3.16% | Add +11.2% | 2,492,925 | $47.8M |
| Commodore Capital LP | 3.37% | Reduce -5.9% | 2,400,000 | $46.0M |
| Alliancebernstein L.P. | 0.01% | Add +3.8% | 2,286,994 | $43.8M |
| Novo Holdings A/S | 2.61% | Reduce -5.7% | 2,250,000 | $43.1M |
| Maverick Capital | 0.71% | Add +2.8% | 2,053,906 | $39.4M |
| Driehaus Capital Management LLC | 0.30% | Reduce -5.8% | 1,875,876 | $36.0M |
| Paradigm Biocapital Advisors LP | 1.21% | Reduce -37.1% | 1,820,079 | $34.9M |
| Adage Capital Partners Gp, L.L.C. | 0.06% | Add +38.6% | 1,670,000 | $32.0M |
| Geode Capital Management, LLC | 0.00% | Add +11.1% | 1,658,980 | $31.8M |
| Perceptive Advisors LLC | 0.79% | Reduce -47.1% | 1,486,508 | $28.5M |
| Loomis Sayles & Co. L P | 0.03% | New | 1,400,381 | $26.8M |
| T. Rowe Price Associates Inc. | 0.00% | Add +2847.7% | 1,326,811 | $25.4M |
| Pictet Asset Management Holding SA | 0.03% | Add +21.8% | 1,248,721 | $23.9M |
| Parkman Healthcare Partners LLC | 2.78% | Add +155.9% | 1,087,634 | $20.8M |
| Vivo Capital, LLC | 2.11% | Reduce -41.5% | 982,576 | $18.8M |
| Goldman Sachs Group Inc. | 0.00% | Add +24.5% | 920,094 | $17.6M |
| Octagon Capital Advisors LP | 2.84% | No change | 870,000 | $16.7M |
| Woodline Partners LP | 0.11% | Reduce -0.7% | 813,647 | $15.6M |
| Eversept Partners, LP | 1.54% | Add +12.8% | 779,998 | $15.0M |
| Yiheng Capital Management, L.P. | 3.18% | Reduce -11.5% | 750,261 | $14.4M |
| Great Point Partners LLC | 6.78% | No change | 750,000 | $14.4M |
| Morgan Stanley | 0.00% | Reduce -26.8% | 739,140 | $14.2M |
| 5AM Venture Management, LLC | 3.37% | No change | 736,595 | $14.1M |
| Candriam S.C.A. | 0.08% | Reduce -2.5% | 731,221 | $14.0M |
| Northern Trust Corp. | 0.00% | Add +19.4% | 694,142 | $13.3M |
| Nuveen Asset Management, LLC | 0.00% | Add +198.2% | 681,012 | $13.1M |
| Schonfeld Strategic Advisors LLC | 0.08% | Reduce -12.1% | 670,600 | $12.9M |
| Cutter Capital Management, LP | 4.94% | Add +21.2% | 628,677 | $12.1M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +11.4% | 575,070 | $11.0M |
| Fisher Asset Management | 0.00% | Add +4.7% | 518,027 | $9.9M |
| UBS Group AG | 0.00% | Add +504.3% | 512,071 | $9.8M |
| Walleye Capital LLC | 0.10% | Reduce -14.0% | 481,639 | $9.2M |
| Ikarian Capital, LLC | 2.57% | Reduce -6.0% | 469,949 | $9.0M |
| Lord, Abbett & Co. LLC | 0.03% | Add +17.3% | 459,588 | $8.8M |
| D. E. Shaw & Co. | 0.01% | Add +220.2% | 442,070 | $8.5M |
| Two Sigma Investments, LP | 0.02% | Reduce -11.9% | 424,537 | $8.1M |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 0.98% | Reduce -33.1% | 423,272 | $8.1M |
| Victory Capital Management Inc. | 0.01% | New | 410,440 | $7.9M |
| Deutsche Bank AG | 0.00% | Add +6.2% | 402,874 | $7.7M |
| Russell Investments Group, Ltd. | 0.01% | Reduce -14.2% | 379,596 | $7.3M |
| Renaissance Technologies | 0.01% | Add +522.8% | 371,200 | $7.1M |
| Millennium Management | 0.01% | Reduce -45.2% | 365,972 | $7.0M |
| Citadel Advisors | 0.01% | Add +48.5% | 358,358 | $6.9M |
| Two Sigma Advisers, LP | 0.01% | Reduce -24.6% | 335,569 | $6.4M |
| Raymond James Financial Inc. | 0.00% | — | 313,787 | $6.0M |
| JPMorgan Chase & Co. | 0.00% | Reduce -24.0% | 304,334 | $5.8M |
| BIT Capital GmbH | 0.48% | Add +239.8% | 285,954 | $5.5M |
| Panagora Asset Management Inc. | 0.02% | Add +50.2% | 253,022 | $4.9M |
| Bank of America Corp. | 0.00% | Add +36.5% | 247,107 | $4.7M |
| Wellington Management Group LLP | 0.00% | Reduce -4.9% | 224,484 | $4.3M |
| Hennion & Walsh Asset Management, Inc. | 0.18% | Add +6.8% | 210,899 | $4.0M |
| Kopp Family Office, LLC | 2.50% | Reduce -0.2% | 205,407 | $3.9M |
| BNP Paribas Financial Markets | 0.00% | New | 203,853 | $3.9M |
| Crestline Management, L.P. | 0.13% | Add +31.7% | 200,857 | $3.9M |
| Bank of New York Mellon Corp | 0.00% | Add +15.0% | 196,522 | $3.8M |
| J. Goldman & Co LP | 0.12% | New | 179,496 | $3.4M |
| Principal Financial Group Inc. | 0.00% | Add +3.3% | 178,444 | $3.4M |
| Rafferty Asset Management, LLC | 0.01% | Add +90.8% | 172,960 | $3.3M |
| Affinity Asset Advisors, LLC | 0.52% | Reduce -69.6% | 159,614 | $3.1M |
| Barclays PLC | 0.00% | Add +25.9% | 157,860 | $3.0M |
| HighVista Strategies LLC | 1.10% | Reduce -16.6% | 154,563 | $3.0M |
| Macquarie Group Ltd. | 0.00% | Reduce -0.7% | 142,393 | $2.7M |
| Boothbay Fund Management, LLC | 0.08% | Reduce -6.0% | 137,918 | $2.6M |
| Citigroup Inc. | 0.00% | Add +194.1% | 135,921 | $2.6M |
| Balyasny Asset Management L.P. | 0.01% | Reduce -61.5% | 130,721 | $2.5M |
| Trexquant Investment LP | 0.03% | Reduce -15.8% | 120,065 | $2.3M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +29.4% | 115,782 | $2.2M |
| American Century Companies Inc. | 0.00% | Add +304.9% | 113,562 | $2.2M |
| Swiss National Bank | 0.00% | Add +4.2% | 112,600 | $2.2M |
| Artia Global Partners LP | 0.77% | New | 100,000 | $1.9M |
| Silverarc Capital Management, LLC | 0.43% | New | 100,000 | $1.9M |
| Rhumbline Advisers | 0.00% | Add +13.1% | 99,938 | $1.9M |
| Algert Global LLC | 0.04% | Reduce -16.1% | 96,393 | $1.8M |
| Susquehanna International Group, LLP | 0.00% | Add +26.3% | 95,865 | $1.8M |
| Merck & Co., Inc. | 0.69% | — | 93,414 | $1.8M |
| Concentric Capital Strategies, LP | 0.11% | New | 88,527 | $1.7M |
| Wells Fargo & Company | 0.00% | Add +31.5% | 64,447 | $1.2M |
| Alps Advisors Inc. | 0.01% | Add +36.8% | 64,057 | $1.2M |
| Legal & General Group Plc | 0.00% | Add +22.7% | 60,202 | $1.2M |
| Moody Aldrich Partners LLC | 0.21% | New | 58,688 | $1.1M |
| Knights of Columbus Asset Advisors LLC | 0.07% | Add +0.3% | 57,711 | $1.1M |
| Caption Management, LLC | 0.04% | New | 56,760 | $1.1M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -82.9% | 55,924 | $1.1M |
| California State Teachers Retirement System | 0.00% | Add +18.0% | 54,710 | $1.0M |
| Rice Hall James & Associates, LLC | 0.06% | New | 53,375 | $1.0M |
| TD Asset Management Inc | 0.00% | New | 51,200 | $982K |
| Manufacturers Life Insurance Company, The | 0.00% | Add +101.0% | 49,720 | $953K |
| Diadema Partners LP | 1.07% | — | 49,478 | $948K |
| Ameriprise Financial Inc. | 0.00% | Add +16.2% | 48,793 | $935K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +40.7% | 48,400 | $930K |
| Jane Street Group, LLC | 0.00% | Reduce -86.3% | 48,022 | $921K |
| Group One Trading LLC | 0.03% | Add +17.7% | 47,995 | $920K |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.